Skip to main content

Thrombosis Group awarded OHMR Award

24th July, 2023

The Thrombosis Group at HRI has been awarded an OHMR award for a PhD Scholarship. The award will support PhD student Cameron Trought in stroke research.

Read more

Dr Jessica Maclean awarded Hillcrest Foundation grant to fight stroke

18th July, 2023

Dr Jessica Maclean has been awarded a grant from the Hillcrest Foundation for research that seeks to revolutionise stroke therapy.

Read more

World-first clinical trials begin for promising new anti-clotting stroke drug

13th July, 2023

HRI has made a breakthrough 25 years in the making, identifying and developing a new anti-clotting drug that shows great promise in the treatment of stroke.

Read more

World first: risk of dementia linked to high cholesterol

21st June, 2023

HRI has made a world-first breakthrough discovery, linking high cholesterol with an increased risk of dementia for the first time.

Read more

Pioneering cardiovascular disease research enabling personalised medical treatment

13th June, 2023

HRI is using innovative fluxomics technology to identify and explore the cell molecular fingerprint unique to each person's cardiovascular disease, with the goal of personalised medicine.

Read more

Is it possible to restore circulation in someone with peripheral artery disease?

8th June, 2023

PhD student Manisha Patil presented the latest research on new avenues to treat peripheral artery disease at the European Society for Microcirculation.

Read more

How a pain in your leg could be just as fatal as a pain in your chest

5th June, 2023

Assoc Prof Mary Kavurma is raising awareness of peripheral artery disease, which is now affecting more women than men and also has greater risk of amputation and cardiovascular mortality.

Read more

Dr Sergey Tumanov awarded grant by The Ian Potter Foundation for innovative Fluxomics Centre

15th May, 2023

HRI's Dr Sergey Tumanov has been awarded a prestigious grant by The Ian Potter Foundation to help establish Australia’s first Fluxomics Centre devoted to cardiovascular disease.

Read more

New strategy to prevent cardiovascular disease hidden in toxic waste product

10th April, 2023

Research shows bilirubin, formerly viewed as only a toxic waste product in the body, could decrease the risk of cardiovascular disease.

Read more

Give

Every donation to the Heart Research Institute is an investment into the lives of millions.

Help us to make a long-lasting difference by donating now.

Other ways you can help